PortfoliosLab logoPortfoliosLab logo
AVAH vs. HCAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVAH vs. HCAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AVAH achieves a -3.06% return, which is significantly higher than HCAT's -28.03% return.


AVAH

1D
1.67%
1M
8.05%
YTD
-3.06%
6M
-11.31%
1Y
67.80%
3Y*
62.37%
5Y*
-8.87%
10Y*

HCAT

1D
-1.15%
1M
33.33%
YTD
-28.03%
6M
-29.51%
1Y
-52.22%
3Y*
-47.01%
5Y*
-50.34%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVAH vs. HCAT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AVAH
Aveanna Healthcare Holdings Inc.
-3.06%78.77%70.52%243.59%-89.46%-38.33%
HCAT
Health Catalyst, Inc.
-28.03%-66.20%-23.65%-12.89%-73.17%-29.78%

Correlation

The correlation between AVAH and HCAT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Apr 28, 2021

0.29

Fundamentals

Market Cap

AVAH:

$1.76B

HCAT:

$124.86M

EPS

AVAH:

$1.20

HCAT:

-$3.74

PS Ratio

AVAH:

0.68

HCAT:

0.40

PB Ratio

AVAH:

7.33

HCAT:

0.90

Total Revenue (TTM)

AVAH:

$2.52B

HCAT:

$302.48M

Gross Profit (TTM)

AVAH:

$823.98M

HCAT:

$103.36M

EBITDA (TTM)

AVAH:

$306.37M

HCAT:

-$85.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVAH vs. HCAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAH
AVAH Risk / Return Rank: 7474
Overall Rank
AVAH Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
AVAH Sortino Ratio Rank: 8080
Sortino Ratio Rank
AVAH Omega Ratio Rank: 7878
Omega Ratio Rank
AVAH Calmar Ratio Rank: 7373
Calmar Ratio Rank
AVAH Martin Ratio Rank: 6868
Martin Ratio Rank

HCAT
HCAT Risk / Return Rank: 1717
Overall Rank
HCAT Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
HCAT Sortino Ratio Rank: 1818
Sortino Ratio Rank
HCAT Omega Ratio Rank: 1919
Omega Ratio Rank
HCAT Calmar Ratio Rank: 1616
Calmar Ratio Rank
HCAT Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVAH vs. HCAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AVAHHCATDifference
Sharpe ratioReturn per unit of total volatility

+1.58

Sortino ratioReturn per unit of downside risk

+2.80

Omega ratioGain probability vs. loss probability

1.27

0.93

+0.34

Calmar ratioReturn relative to maximum drawdown

1.73

-0.69

+2.42

Martin ratioReturn relative to average drawdown

3.06

-1.14

+4.20

AVAH vs. HCAT - Sharpe Ratio Comparison

The current AVAH Sharpe Ratio is 1.00, which is higher than the HCAT Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of AVAH and HCAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AVAH vs. HCAT - Drawdown Comparison

The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum HCAT drawdown of -98.30%. Use the drawdown chart below to compare losses from any high point for AVAH and HCAT.


Loading charts...

Drawdown Indicators


AVAHHCATDifference

Max Drawdown

Largest peak-to-trough decline

-94.76%

-98.30%

+3.54%

Max Drawdown (1Y)

Largest decline over 1 year

-39.44%

-75.64%

+36.20%

Max Drawdown (3Y)

Largest decline over 3 years

-41.40%

-93.04%

+51.64%

Max Drawdown (5Y)

Largest decline over 5 years

-94.68%

-98.29%

+3.61%

Current Drawdown

Current decline from peak

-38.56%

-97.07%

+58.51%

Average Drawdown

Average peak-to-trough decline

-63.48%

-62.65%

-0.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.24%

45.76%

-23.52%

Volatility

AVAH vs. HCAT - Volatility Comparison

The current volatility for Aveanna Healthcare Holdings Inc. (AVAH) is 13.13%, while Health Catalyst, Inc. (HCAT) has a volatility of 43.31%. This indicates that AVAH experiences smaller price fluctuations and is considered to be less risky than HCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AVAHHCATDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.13%

43.31%

-30.18%

Volatility (6M)

Calculated over the trailing 6-month period

32.64%

71.92%

-39.28%

Volatility (1Y)

Calculated over the trailing 1-year period

68.26%

91.07%

-22.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.23%

71.50%

+6.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.32%

67.98%

+9.34%

Dividends

AVAH vs. HCAT - Dividend Comparison

Neither AVAH nor HCAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AVAH vs. HCAT - Financials Comparison

This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Health Catalyst, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
647.92M
70.76M
(AVAH) Total Revenue
(HCAT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVAH and HCAT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HCAT has higher volatility (43.31%) compared to AVAH (13.13%). In terms of maximum drawdown, AVAH dropped -94.76% vs HCAT's -98.30%.

AVAH currently has the higher Sharpe Ratio (1.00 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AVAH and HCAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer